Trevena reports positive top-line results from two Phase III trials of oliceridine in acute pain

US-based biopharmaceutical company Trevena has reported positive top-line results from two Phase III clinical trials (APOLLO-1 and APOLLO-2) of oliceridine to treat moderate-to-severe acute pain after bunionectomy and abdominoplasty
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news